BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lv X, Sun J, Hu L, Qian Y, Fan C, Tian N. Curcumol inhibits malignant biological behaviors and TMZ-resistance in glioma cells by inhibiting long noncoding RNA FOXD2-As1-promoted EZH2 activation. Aging (Albany NY) 2021;13:24101-16. [PMID: 34739394 DOI: 10.18632/aging.203662] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
Number Citing Articles
1 Yu YH, Zhang HJ, Yang F, Xu L, Liu H. Curcumol, a major terpenoid from Curcumae Rhizoma, attenuates human uterine leiomyoma cell development via the p38MAPK/NF-κB pathway. J Ethnopharmacol 2023;310:116311. [PMID: 36894110 DOI: 10.1016/j.jep.2023.116311] [Reference Citation Analysis]
2 Hu G, Chen W, Peng W, Huang Z, Dong Z, Cao Y. Cincumol prevents malignant phenotype of colorectal cancer cell line HCT116 via inhibiting PI3K/AKT signaling in vitro. Acta Cir Bras 2023;37:e371201. [PMID: 36651426 DOI: 10.1590/acb371201] [Reference Citation Analysis]
3 Dong J, Peng Y, Zhong M, Xie Z, Jiang Z, Wang K, Wu Y. Implication of lncRNA ZBED3-AS1 downregulation in acquired resistance to Temozolomide and glycolysis in glioblastoma. Eur J Pharmacol 2022;938:175444. [PMID: 36462734 DOI: 10.1016/j.ejphar.2022.175444] [Reference Citation Analysis]
4 Wang J, Jin J, Chen T, Zhou Q. Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages. Molecules 2022;27:4345. [DOI: 10.3390/molecules27144345] [Reference Citation Analysis]